slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,129
Current window 22,471-22,500
Pages 2,605
Rows per page 30
Component
22,471-22,500 of 78,129
71
The slide demonstrates efficacy and synergy in vivo for a drug candidate ('565) in DLBCL models.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
72
The slide uses two dose-response curves to demonstrate selectivity.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
11
The slide contrasts irreversible inhibition (depletion) with reversible inhibition (recovery).Exscientia | Results Presentation Deck | 24 slides · Exscientia
Conference presentation Investor relations Beat · EvidenceLoop · Before After2 hits
12
The slide includes two charts: a line chart showing tumour volume over time and a dot plot showing plasma pro-GRP concentration reduction.Exscientia | Results Presentation Deck | 24 slides · Exscientia
Conference presentation Investor relations Beat · EvidenceLoop · Before After2 hits
13
The slide uses box plots for aggregate data and line charts for individual patient sample responses, categorized by differentiation level.Exscientia | Results Presentation Deck | 24 slides · Exscientia
Conference presentation Investor relations Beat · Evidence2 hits
14
The slide uses a heatmap to visualize synergy (green) vs no synergy (light green) across different drug combinations.Exscientia | Results Presentation Deck | 24 slides · Exscientia
Conference presentation Investor relations Beat · Evidence2 hits
17
Data shows significant synergistic effects in both models, with OCI-Ly10 showing regression and TMD8 showing synergy despite ibrutinib monotherapy inactivity.Exscientia | Results Presentation Deck | 24 slides · Exscientia
Conference presentation Investor relations 2 hits
18
The slide shows dose-response curves for 11 patient samples. The left chart shows significant inhibition of CLL cells (IC50 0.4 µM), while the right chart shows minimal impact on T-cell viability.Exscientia | Results Presentation Deck | 24 slides · Exscientia
Conference presentation Investor relations 2 hits
16
The left chart is a conceptual matrix showing ACV growth relative to users and product/data usage. The right chart shows specific ARR growth for two clients.FiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations 2 hits
21
The slide uses a combination of a grouped bar chart for internal performance and a single bar chart for peer benchmarking.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Financials2 hits
22
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Financials2 hits
14
The slide contrasts a chemotherapy-based approach (SMDC) with a radioligand therapy (RLT) approach, highlighting the superior PSA response in the RLT cohort.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 2 hits
25
The slide presents clinical trial data comparing pharmacokinetics and safety (thrombocytopenia) profiles.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 2 hits
12
The slide includes two bar charts and two corresponding data tables showing quarterly performance and 5-year average percentage distribution.Hagerty | Investor Presentation Deck | 18 slides · Hagerty
Conference presentation Investor relations 2 hits
12
The slide highlights a strategic shift toward higher quality relationships, evidenced by the metrics on the right.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Satisfaction2 hits
14
The slide uses two line charts to demonstrate a downward trend in risk metrics over time, paired with a list of qualitative management actions.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Satisfaction2 hits
15
Includes a pro-forma note regarding AOCI losses.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Satisfaction2 hits
21
The slide highlights a 40-year track record of dividend growth/maintenance.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action2 hits
23
Includes historical annual NIM data and quarterly trend lines for yield on loans, securities, and cost of deposits.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action2 hits
26
The slide tracks two key financial efficiency metrics over time, showing a downward trend in core expenses relative to assets.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action2 hits
33
The slide provides a snapshot of risk and diversification for a specific loan segment.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action2 hits
36
Includes a waterfall-style chart for uninsured deposits and a stacked bar chart for deposit flows.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action2 hits
17
Includes legend for stacked bar charts and footnotes regarding accounting treatment.Hexagon Purus | Investor Presentation Deck | 33 slides · Hexagon Purus
Conference presentation Investor relations Beat · Financials2 hits
27
The chart uses a mirrored bar chart layout to contrast positive revenue against negative EBITDA figures.Hexagon Purus | Investor Presentation Deck | 33 slides · Hexagon Purus
Conference presentation Investor relations 2 hits
02
Hexagon Purus | Results Presentation Deck | 23 slidesHexagon Purus | Results Presentation Deck | 23 slides · Hexagon Purus
Conference presentation Investor relations 2 hits
20
The slide uses stacked bar charts to show composition (single vs multi-subscribers, online vs wholesale revenue) and a line chart for revenue per subscriber.Hims & Hers | Results Presentation Deck | 29 slides · Hims & Hers
Conference presentation Investor relations Beat · KPI OverviewLoop · Cost Of Inaction2 hits
21
The chart uses a combination of bar and line elements to show the transition from negative to positive EBITDA and margin expansion.Hims & Hers | Results Presentation Deck | 29 slides · Hims & Hers
Conference presentation Investor relations Beat · KPI OverviewLoop · Cost Of Inaction2 hits
08
The chart uses a line for sales and bars for EBIT margin, with a clear inflection point post-2020.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Solution2 hits
20
The slide uses a combination of bar charts and process flow diagrams to illustrate growth and efficiency targets.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Solution2 hits
22
The slide includes a line chart showing historical and projected Capex/Sales ratios and a pie chart showing the allocation of Capex.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Market Size2 hits